Navigation Links
Mirixa Announces Agreement With the Pharmacy Guild of Australia
Date:10/14/2008

MirixaPro(SM) chosen to enable patient care services in Australia through

retail pharmacies nationwide

TAMPA, Fla., Oct. 14 /PRNewswire/ -- NCPA 110th Annual Convention -- Mirixa Corporation, the leader in pharmacy-based patient care services and healthlinks.net, a subsidiary of the Pharmacy Guild of Australia, announced today that they have signed a definitive technology licensing and business consulting agreement, paving the way for the use of MirixaPro(SM) in Australia's pharmacies nationwide. Mirixa Australia, a newly formed business venture, will be operated by the Guild's healthlinks.net subsidiary.

Under the agreement, Mirixa, which is sponsored by the National Community Pharmacists Association (NCPA), will adapt and license its widely used web-based software, MirixaPro(SM), for use by pharmacies in Australia. Additionally, Mirixa's success and leadership in enabling patient care services, through its U.S. network of 46,000 contracted pharmacies, will be leveraged by the Guild as it builds its Australian national program. The Guild will initially deploy Mirixa technology and services to facilitate improved medication adherence and outcomes via programs that harness the power of the pharmacist-patient relationship.

"Medication non-adherence is a challenging and complex global problem that results in poor health and increased health care costs," said Kos Sclavos, National President of the Pharmacy Guild of Australia. "After investigating several options, it became clear that Mirixa's experience and advanced technology provide us with the ability to quickly introduce programs that improve medication adherence and healthcare outcomes in Australia. We are looking forward to working with the Mirixa team to bring technology-enabled services to pharmacists and their patients across Australia," added Mr. Sclavos.

"The partnership between Mirixa and the Pharmacy Guild of Australia is a culmination of years of conversations with our international pharmacy partners. The endorsement of Mirixa and MirixaPro is a testament to our emphasis on the pharmacy and patient care relationship, and the realization of that focus by our partners in Australia," said Bruce T. Roberts, Chief Executive Officer and Executive Vice President, NCPA.

"The Pharmacy Guild of Australia has a widely recognized track record of innovation in technology and services at pharmacy, and we're honored to have them as a business partner," expressed Rick Solano, Mirixa's Chief Executive Officer. "We foresee a bright future of collaboration with the Guild, and look forward to demonstrating the clear value that community pharmacy brings to improving the safety, quality and effectiveness of patient care worldwide," added Mr. Solano.

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the healthcare community to deliver patient care services through retail pharmacy. Mirixa's web-based clinical application, MirixaPro(SM), is used by pharmacists to deliver standardized patient care services. For more information, please visit http://www.Mirixa.com.

About The Pharmacy Guild of Australia

The Pharmacy Guild of Australia was established in 1928, bringing together several small retail pharmacy organizations then operating in the various States. Its members are owners of some 4,500 pharmacies throughout Australia. The development of policy is the responsibility of the Guild's supreme governing body, the National Council, on which all State and Territory Branches are represented. Implementation of policy is overseen by the National Executive and effected through the National Secretariat. For more information, please visit http://www.guild.org.au.

About NCPA

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more please visit http://www.ncpanet.org.

Contacts: Christine Ryba Roma Cecere

703.865.2041 61 2 9744 4405

PR@Mirixa.com RCecere@healthlinks.net.au


'/>"/>
SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mirixa Corporation and the APhA Foundation Form Partnership
2. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
3. BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board
4. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
5. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
6. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
7. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
8. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
9. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
10. Pathwork Diagnostics Announces Key Additions to Management Team
11. The Michigan Life Sciences Pipeline Announces The Funding Place(TM) and Other Resources to Connect Investors and Startups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... Litmus Health ... announced its full advisory board. The board comprises leaders spanning business, technology, academia, ... PhD, former VP of Engineering, to Chief Technology Officer. Crooks will lead strategy ...
(Date:7/20/2017)... and PLYMOUTH, Minn., July 20, 2017   KCNQ2 ... personalized genetic evaluations company, today announced that they ... investigating a genetic mutation implicated in KCNQ2 epileptic ... partnership for a second case involving an additional ... KCNQ2 Cure Alliance and Pairnomix entered into a ...
(Date:7/18/2017)... ... July 18, 2017 , ... ... and biotherapeutics development, announces the launch of a new NTA biosensor chip for ... researchers to study the kinetics of polyhistidine-tagged (His-tagged) molecules quickly and reliably. ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... the United States Patent and Trademark Office for its Patent Applications 14/858,857 and ... Office’s allowances of these patent applications further expand the protection of G-CON’s R&D ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
Breaking Biology News(10 mins):